세계의 유전자 편집 시장 규모는 2025년 108억 달러에서 2025년부터 2030년까지 예측 기간 동안 CAGR 16.9%로 추이해, 2030년 말에는 237억 달러에 달할 것으로 예측되고 있습니다.
기술별로는 CRISPR-Cas 부문이 2025년 78억 달러에서 예측 기간 동안 CAGR 17.4%로 추이하고 2030년 말에는 173억 달러에 이를 것으로 예측되고 있습니다. TALEN 부문은 2025년 13억 달러에서 예측 기간 동안 CAGR 15.6%로 추이하고, 2030년 말에는 27억 달러에 달할 것으로 예측되고 있습니다.
이 보고서는 세계 유전자 편집 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석 등을 정리했습니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 요약
제2장 시장 개요
개요 및 시장 정의
거시경제 요인
Porter's Five Forces 모델
제3장 시장 역학
시장 역학
시장 성장 촉진요인
유전성 질환의 유병률
새로운 유전자 편집 기술과 응용
정부와 민간으로부터의 자금 제공 증가
시장 성장 억제요인
정부의 정책과 규제
윤리적 및 사회적 우려
시장 기회
CRISPR 기술의 응용 확대
식물 및 가축 육종에의 응용
시장의 과제
유전자 편집 워크플로우에서 확장성의 제약
CRISPR 기반 치료 비용
제4장 규제 상황
국가/지역별 규제 시나리오
북미
EU
아시아태평양
기타 지역
제5장 신기술과 개발
신흥기술
CRISPR의 생체내 전달
개량형 Cas Variant
AI
요약 : CRISPR의 신기술
임상시험 분석
임상시험 분석 : 연구 유형별
임상시험 분석 : 상태별
임상시험 분석 : 위상별
주요 임상시험
요약 : 임상시험의 상황
특허 분석
특허 : 연도별
특허 : 주요 출원인별
특허 : 주요 특허 보유자별
유전자 편집 기술에 관한 최근 특허
지적재산분쟁과 특허문제
중요한 포인트 : 특허 상황
제6장 시장 부문 분석
세분화의 내역
세계의 유전자 편집 시장 : 기술별
CRISPR-Cas
TALEN
ZFN
기타 유전자 편집 플랫폼
세계의 유전자 편집 시장 : 용도별
의약품 개발
식물 육종
진단
임상요법
기타
세계의 유전자 편집 시장 : 최종 사용자별
바이오의약품기업
농업 생명공학
연구기관
기타
지리적 내역
세계의 유전자 편집 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제7장 경쟁 정보
시장 랭킹 분석
전략 분석
최종 요약
제8장 유전자 편집 시장에서의 지속가능성 : ESG의 관점
ESG: 소개
유전자 편집의 지속가능성 : ESG의 관점
ESG의 문제
ESG 성능 분석
환경 성능
사회적 퍼포먼스
거버넌스 퍼포먼스
BCC의 결론
제9장 부록
조사 방법
참고문헌
약어
기업 프로파일
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CELLECTIS SA
CRISPR THERAPEUTICS
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
MERCK KGAA
ORIGENE TECHNOLOGIES INC.
PRECISION BIOSCIENCES
SANGAMO THERAPEUTICS
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
VERVE THERAPEUTICS INC.
JHS
영문 목차
영문목차
The global market for genome editing is expected to grow from $10.8 billion in 2025 and is projected to reach $23.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.9% during the forecast period of 2025 to 2030.
The market for CRISPR-Cas genome editing technology is expected to grow from $7.8 billion in 2025 and is projected to reach $17.3 billion by the end of 2030, at a CAGR of 17.4% during the forecast period of 2025 to 2030.
The market for TALEN genome editing technology is expected to grow from $1.3 billion in 2025 and is projected to reach $2.7 billion by the end of 2030, at a CAGR of 15.6% during the forecast period of 2025 to 2030.
Report Scope
This report analyzes the market for genome editing technologies, applications and end users, offering insights into the market and technological trends. The study focuses on technologies such as CRISPR-Cas, transcription activator-like effector nucleases (TALEN) and zinc finger nucleases (ZFN), assessing their adoption in biopharmaceutical, agricultural biotech and research sectors. The market is segmented by applications into drug development, plant breeding, diagnostics and clinical therapy.
The report provides an analysis covering the regions of North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa. It evaluates the drivers, restraints, opportunities and challenges affecting the market and vendor landscape. It discusses clinical trials, patents and emerging technologies related to the market and looks at ESG-related developments.
The study offers an analysis of the competitive landscape, which ranks the top companies in the global market for genome editing. It also has a section with company profiles covering details of the market leaders. For market estimates, data has been provided for 2022 and 2023 as the historic years, 2024 as the base year, and forecasts for 2025 to 2030.
Report Includes
52 data tables and 58 additional tables
A review of the global market for genome editing technologies
Analyses of the global market trends, with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Evaluation and forecast of the genome editing market, and a corresponding market share analysis by product, application, end user and geographic region
In-depth facts and figures concerning market drivers and deterrents, and other macroeconomic forces influencing the genome editing market
A look at the use of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, and how it has fueled the growth of the genome editing industry
An evaluation of the recent technological breakthroughs and issues, market regulations, and the current status of the intellectual property rights of the CRISPR-Cas9 genome editing technology
Review of patent trends and research publications in the global genome editing industry
Insight into the industry structure, competitive landscape, R&D activity, growth strategies and ESG trends
Identification of the companies best positioned to meet market demand due to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
Profiles of the leading companies, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics, and Cellectis S.A.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview and Market Definition
Macroeconomic Factors
Porter's Five Forces Model
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Competition in the Industry
Threat of Substitutes
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Prevalence of Genetic Disorders
New Genome-Editing Technologies and Applications
Increasing Government and Private Funding
Market Restraints
Governmental Policies and Regulations
Ethical and Societal Concerns
Market Opportunities
Expanding Applications for CRISPR Technology
Applications in Plant and Livestock Breeding
Market Challenges
Scalability Constraints in Gene Editing Workflows
Cost of CRISPR-based Therapy
Chapter 4 Regulatory Landscape
Regulatory Scenario, by Country/Region
North America
EU
Asia-Pacific
Rest of the World
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
In Vivo Delivery of CRISPR
Improved Cas Variants
Artificial Intelligence
Takeaways: Emerging Technologies in CRISPR
Clinical Trials Analysis
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Selected Clinical Trials
Takeaways: Clinical Trials Landscape
Patent Analysis
Patents, by Year
Patents, by Leading Applicant
Patents, by Leading Patent Holder
Recent Patents Relating to Genome Editing Technology
IP Disputes and Patent Issues
Key Takeaways: Patent Landscape (2020-2024)
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Genome Editing Market, by Technology Type
CRISPR-Cas
TALEN
ZFNs
Other Genome Editing Platforms
Global Genome Editing Market, by Application
Drug Development
Plant Breeding
Diagnostics
Clinical Therapy
Other Applications
Global Genome Editing Market, by End User
Biopharmaceutical Companies
Agricultural Biotechnology
Research Institutions
Other End Users
Geographic Breakdown
Global Genome Editing Market, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Market Ranking Analysis
Strategic Analysis
Final Takeaways
Chapter 8 Sustainability in the Genome Editing Market: ESG Perspective
Introduction to ESG
Sustainability in Genome Editing: An ESG Perspective
